NG
OPK icon

Northstar Group’s Opko Health OPK Stock Holding History

Northstar Group’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,785
Closed -$41.4K – 159
2024
Q3 		$41.4K Hold
27,785
– – 0.01% 156
2024
Q2 		$34.7K Hold
27,785
– – 0.01% 146
2024
Q1 		$33.3K Hold
27,785
– – 0.01% 149
2023
Q4 		$42K Buy
+27,785
New +$40.2K 0.01% 143

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northstar Group's OPK Position: Q4 2024 in Review

Northstar Group sold out of Opko Health (OPK) in Q4 2024, closing a stake of 27,785 shares — an estimated $41.4K sold.

Northstar Group first reported a position in OPK in Q4 2023 and held it in 4 quarters. The position peaked at $42K in Q4 2023. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Northstar Group reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Northstar Group sold 27,785 Opko Health shares in Q4 2024, an estimated $41.4K.
  • Northstar Group first reported a position in Opko Health in Q4 2023 and held it in 4 quarters.
  • Northstar Group's Opko Health position peaked at $42K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Northstar Group's 13F filing for Q4 2024, filed 28 Jan 2025.